An inhibitor of leukotriene synthesis affects vasopressin secretion following osmotic stimulus in rats


Autoria(s): Santos, Josilene Fioravanti dos; Oliveira-Pelegrin, Gabriela Ravanelli de; Athayde, Leticia Antunes; Alves da Rocha, Maria Jose
Contribuinte(s)

UNIVERSIDADE DE SÃO PAULO

Data(s)

18/09/2013

18/09/2013

2012

Resumo

Previous studies revealed the presence of LTC4 synthase in paraventricular vasopressinergic neurons, suggesting a role for leukotrienes (LTs) in certain neuroendocrine system functions. Our aim was to study the effect of an inhibitor of LT synthesis in the release of arginine vasopressin (AVP) following an osmotic stimulus in rats. Male Wistar rats received an intra-cerebroventricular injection of 2 mu l of the LT synthesis inhibitor MK-886 (1, 2, or 4 mu g/kg), or vehicle (DMSO 5%), 1 h before an intraperitoneal injection of hypertonic saline (NaCl 2 M) or isotonic saline (NaCl 0.01 M) in a volume corresponding to 1% of body weight. Thirty minutes after the osmotic stimulus, the animals were decapitated and blood was collected for determining hematocrit, plasma osmolality and plasma AVP levels. As expected, the injection of hypertonic saline significantly increased (P<0.05) the hematocrit, plasma osmolality and plasma AVP levels. While inhibiting LT synthesis by central administration of MK-886 did not cause any additional increase in hematocrit or osmolality, plasma AVP levels were augmented (P<0.05). We conclude that central leukotrienes may have a modulatory role in AVP secretion following an osmotic stimulus, this deserving future studies. (C) 2012 Elsevier B.V. All rights reserved.

FAPESP

FAPESP

CNPq

CNPq

Identificador

REGULATORY PEPTIDES, AMSTERDAM, v. 179, n. 41334, pp. 6-9, 2012

0167-0115

http://www.producao.usp.br/handle/BDPI/33462

10.1016/j.regpep.2012.08.012

http://dx.doi.org/10.1016/j.regpep.2012.08.012

Idioma(s)

eng

Publicador

ELSEVIER SCIENCE BV

AMSTERDAM

Relação

REGULATORY PEPTIDES

Direitos

closedAccess

Copyright ELSEVIER SCIENCE BV

Palavras-Chave #ANTIDIURETIC HORMONE #NEUROENDOCRINE SYSTEM #HYPEROSMOLALITY #FLAP INHIBITOR #ARGININE-VASOPRESSIN #RELEASE #5-LIPOXYGENASE #ACTIVATION #EXPRESSION #ENDOCRINOLOGY & METABOLISM #PHYSIOLOGY
Tipo

article

original article

publishedVersion